January 11 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Wednesday that its sales increased by 15% on the year in 2022.
The company registered a 10% increase in domestic sales last year, while exports rose by 19%, Sopharma said in a bourse filing.
In December alone, Sopharma's sales increased by a yearly 19%, including 14% growth in domestic sales and a 21% rise in exports.
At the end of November, the drug maker reported a consolidated net profit of 67.9 million levs ($37.23/34.72 million euro) for the first nine months of 2022, up from 50.5 million levs the previous year.
As of 1330 CET on Wednesday, shares in Sopharma traded flat at 4.50 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)